TD Waterhouse Canada’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.3K | Sell |
23,353
-87
| -0.4% | -$303 | ﹤0.01% | 1013 |
|
|
2025
Q1 | $48.7K | Sell |
23,440
-81,154
| -78% | -$169K | ﹤0.01% | 1096 |
|
|
2024
Q4 | $306K | Sell |
104,594
-127,830
| -55% | -$375K | ﹤0.01% | 714 |
|
|
2024
Q3 | $595K | Sell |
232,424
-13,180
| -5% | -$33.7K | ﹤0.01% | 585 |
|
|
2024
Q2 | $681K | Sell |
245,604
-12,718
| -5% | -$35.2K | 0.01% | 549 |
|
|
2024
Q1 | $1.13M | Buy |
258,322
+192
| +0.1% | +$843 | 0.01% | 480 |
|
|
2023
Q4 | $1.58M | Sell |
258,130
-71,471
| -22% | -$437K | 0.01% | 358 |
|
|
2023
Q3 | $1.52M | Sell |
329,601
-244,314
| -43% | -$1.13M | 0.02% | 355 |
|
|
2023
Q2 | $4.24M | Buy |
573,915
+91,282
| +19% | +$674K | 0.04% | 230 |
|
|
2023
Q1 | $4.25M | Sell |
482,633
-30,931
| -6% | -$272K | 0.04% | 224 |
|
|
2022
Q4 | $5.77M | Sell |
513,564
-14,096
| -3% | -$158K | 0.06% | 182 |
|
|
2022
Q3 | $6.36M | Buy |
527,660
+173,184
| +49% | +$2.09M | 0.07% | 162 |
|
|
2022
Q2 | $4.55M | Sell |
354,476
-2,150
| -0.6% | -$27.6K | 0.05% | 208 |
|
|
2022
Q1 | $4.28M | Buy |
356,626
+175,671
| +97% | +$2.11M | 0.04% | 232 |
|
|
2021
Q4 | $2.84M | Buy |
+180,955
| New | +$2.84M | 0.03% | 309 |
|